Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical trial NCT02926833 · COMPLETED
Trial details
- NCT number
- NCT02926833
- Sponsor
- Kite, A Gilead Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-29
- Primary completion
- 2023-01-12
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.